Literature DB >> 9707166

Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft.

M M Dollinger1, S E Howie, J N Plevris, A M Graham, P C Hayes, D J Harrison.   

Abstract

Liver allograft rejection is mediated by a primary response of T lymphocytes, followed by infiltration of the graft with a mixed inflammatory reaction. Using single and double label immunocytochemistry, we examined the proliferation index and the phenotype of leukocytes on liver biopsies from 10 patients with acute rejection before and after treatment with i.v. steroids, 10 patients with chronic rejection, 10 patients without rejection posttransplant, and 15 nongrafted, nonimmunosuppressed patients. Proliferation of mononuclear leukocytes (assessed by expression of Ki-67, a nuclear antigen associated with the cell cycle) inside the allograft was a prominent feature of acute and chronic rejection and was down-regulated by steroid treatment. Leukocytes in cell cycle were located predominantly in the portal tracts at the site of the inflammatory infiltrate. The majority of 'naive' (CD45RA+) and 'memory' (CD45RO+) CD4+ T lymphocytes were also periportally distributed. In contrast, CD8+ T lymphocytes, CD57+ natural killer cells, and CD68+ macrophages were located intraparenchymally throughout the liver lobules, whereas CD20+ B lymphocytes were only present in some of the portal tracts. Predominantly CD4+ and occasionally CD8+ lymphocytes were proliferating (assessed by double staining). The proliferating CD4+ cells were of both naive (CD4+, CD45RA+) and memory (CD4+, CD45RO+) phenotypes. To our knowledge, this is the first description of proliferating naive T lymphocytes in situ in liver allografts. These findings suggest that there may be a primary immune response generated within the allograft as well as in draining lymphatic tissue. This implicates not only intrahepatic proliferation of T lymphocytes as a prominent feature of rejection, but also suggests that the liver has a special immunological status comparable to that of lymphatic tissue.

Entities:  

Mesh:

Year:  1998        PMID: 9707166     DOI: 10.1096/fasebj.12.11.939

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells.

Authors:  Johannes Moeller; Manfred G Krukemeyer; Lars Morawietz; Max Schmeding; Anja Dankof; Ulf Neumann; Veit Krenn; Claudia Berek
Journal:  Virchows Arch       Date:  2005-02-16       Impact factor: 4.064

2.  Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.

Authors:  H Xu; K P Samy; A Guasch; S I Mead; A Ghali; A Mehta; L Stempora; A D Kirk
Journal:  Am J Transplant       Date:  2015-10-05       Impact factor: 8.086

3.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.

Authors:  Allister J Grant; Sarah Goddard; Jalal Ahmed-Choudhury; Gary Reynolds; David G Jackson; Michael Briskin; Lijun Wu; Stefan G Hübscher; David H Adams
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortium.

Authors:  I Ashoor; N Najafian; Y Korin; E F Reed; T Mohanakumar; D Ikle; P S Heeger; M Lin
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

5.  Down regulation of CD45 expression on CD4 T cells during acute renal allograft rejection: evidence of a decline in T suppressor/inducer activity.

Authors:  M Shabtai; W C Waltzer; A Ayalon; E L Shabtai; K Malinowski
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

6.  Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report.

Authors:  Runmei Li; Fang Yan; Liang Liu; Hui Li; Baozhu Ren; Zhenzhen Hui; Xiubao Ren
Journal:  Oncol Lett       Date:  2016-01-14       Impact factor: 2.967

7.  Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following polymorphonuclear cell depletion.

Authors:  Nick D Jones; Matthew O Brook; Manuela Carvalho-Gaspar; Shiqao Luo; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2010-09-24       Impact factor: 5.532

8.  Changes in the number of circulating TCM and TEM subsets in renal transplantation: relationship with acute rejection and induction therapy.

Authors:  David S Segundo; Gema Fernández-Fresnedo; María Gago; Iñaki Beares; Marta González; Juan C Ruiz; Manuel Arias; Marcos López-Hoyos
Journal:  Kidney Int Suppl (2011)       Date:  2011-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.